On May 5, 2021, as a part of CMS’ ongoing COVID response efforts to support the long term care community, we debuted our first social media videos highlighting staff, also referred to as Community Champions, who moved from being initially uncertain about receiving the COVID-19 vaccine to accepting the vaccine-- and encouraging their peers to do the same.

Throughout the COVID-19 pandemic, staff in nursing homes have been providing ongoing care to our nation’s most vulnerable.  This social media campaign is intended to help increase vaccine acceptance amongst long-term care staff. Please like and share our Community Champions video:  https://youtu.be/k0WbAhveyDY  We can do this!

Questions about the COVID 19 vaccines? Visit https://www.cdc.gov/coronavirus/2019-ncov/vaccines/

CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine.

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.

Vaccine monitoring for the 2 COVID-19 vaccines in the first month of use has found the vaccines to be very safe, with no serious safety problems detected

https://www.cdc.gov/mmwr/volumes/70/wr/mm7008e3.htm?s_cid=mm7008e3_w#F1_down

Leading Age is hosting a Webinar entitled Vaccines and Vaccinations: Legal and operational Issues. Thursday, January 21 from 2-3 pm ET. Cost is $99. for LeadingAge members and $198 for nonmembers. Click here to view more information.

Talk to Dr. Sarah Berry during an open Zoom call to have your questions about the COVID-19 vaccine answered! Email us at NHCovidVaccine@inther.com to get call in information!